Kristie Colvin, the SVP and CAO of $CNP, sold 16,357 shares of the company on 02-24-2025 for an estimated $557,855. We received data on the trade from a recent SEC filing. This was a sale of approximately 12.1% of their shares of this class of stock. Following this trade, they now own 118,882 shares of this class of $CNP stock.
$CNP Insider Trading Activity
$CNP insiders have traded $CNP stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CNP stock by insiders over the last 6 months:
- KRISTIE COLVIN (SVP and CAO) has made 0 purchases and 2 sales selling 16,536 shares for an estimated $563,955.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CNP Hedge Fund Activity
We have seen 321 institutional investors add shares of $CNP stock to their portfolio, and 304 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 27,799,744 shares (+156.4%) to their portfolio in Q4 2024, for an estimated $882,085,877
- MIZUHO SECURITIES USA LLC removed 9,904,232 shares (-99.4%) from their portfolio in Q4 2024, for an estimated $314,261,281
- BROOKFIELD CORP /ON/ added 5,179,639 shares (+inf%) to their portfolio in Q4 2024, for an estimated $164,349,945
- PRICE T ROWE ASSOCIATES INC /MD/ removed 3,654,302 shares (-40.5%) from their portfolio in Q4 2024, for an estimated $115,951,002
- AMERICAN CENTURY COMPANIES INC added 3,185,932 shares (+1431.1%) to their portfolio in Q4 2024, for an estimated $101,089,622
- PICTET ASSET MANAGEMENT HOLDING SA removed 2,371,636 shares (-19.3%) from their portfolio in Q4 2024, for an estimated $75,252,010
- REAVES W H & CO INC removed 1,978,940 shares (-41.7%) from their portfolio in Q4 2024, for an estimated $62,791,766
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
